Monte Rosa Therapeutics announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors. Dr. Skvarka currently serves as the Executive Chairman of DEM BioPharma, Inc., and as a Board Member of Zentalis Pharmaceuticals.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GLUE:
- Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors
- Monte Rosa Therapeutics reports Q4 EPS (63c), consensus (62c)
- Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
- Monte Rosa Therapeutics to Present at Upcoming Investor Conferences
